Is aromatase expression in uterine leiomyomata regulated primarily by proximal promoters I.3/II?
The primary in vivo aromatase promoter in leiomyoma tissues in non-Asian U.S. women is the prostaglandin E(2)/cAMP-responsive I.3/II region. Alternative signals may stimulate aromatase expression that is a common biological phenotype in uterine leiomyomata.
Classification of nonepileptic seizures is useful in predicting outcome and may be valuable in further investigation of this complex set of disorders.